These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1416858)

  • 1. Teicoplanin metabolism in humans.
    Bernareggi A; Borghi A; Borgonovi M; Cavenaghi L; Ferrari P; Vékey K; Zanol M; Zerilli LF
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1744-9. PubMed ID: 1416858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the normal and branched-chain acyl moieties of teicoplanin components produced by Actinoplanes teichomyceticus.
    Borghi A; Edwards D; Zerilli LF; Lancini GC
    J Gen Microbiol; 1991 Mar; 137(3):587-92. PubMed ID: 1827835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and structure determination of two new analogs of teicoplanin, a glycopeptide antibiotic.
    Borghi A; Antonini P; Zanol M; Ferrari P; Zerilli LF; Lancini GC
    J Antibiot (Tokyo); 1989 Mar; 42(3):361-6. PubMed ID: 2523370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of individual components of teicoplanin in man.
    Bernareggi A; Danese A; Cometti A; Buniva G; Rowland M
    J Pharmacokinet Biopharm; 1990 Dec; 18(6):525-43. PubMed ID: 2149149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin).
    Borghi A; Coronelli C; Faniuolo L; Allievi G; Pallanza R; Gallo GG
    J Antibiot (Tokyo); 1984 Jun; 37(6):615-20. PubMed ID: 6235204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and structure determination of the main related substances of teicoplanin, a glycopeptide antibiotic.
    Cometti A; Gallo GG; Kettenring J; Panzone GB; Tuan G; Zerilli LF
    Farmaco Sci; 1988 Dec; 43(12):1005-18. PubMed ID: 2977757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of teicoplanin in infants and children.
    Reed MD; Yamashita TS; Myers CM; Blumer JL
    J Antimicrob Chemother; 1997 Jun; 39(6):789-96. PubMed ID: 9222049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and bone concentrations of teicoplanin and vancomycin: study in an animal model.
    Drago L; De Vecchi E; Fassina MC; Gismondo MR
    Drugs Exp Clin Res; 1998; 24(4):185-90. PubMed ID: 10051964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPLC quantitation of the six main components of teicoplanin in biological fluids.
    Jehl F; Monteil H; Tarral A
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():53-9. PubMed ID: 2965132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-HRMS based on mixed-mode chromatography for the separation of teicoplanin and the unravelment of its composition.
    García-Gómez D; Alonso Díaz B; Rodríguez-Gonzalo E
    J Pharm Biomed Anal; 2020 Jul; 186():113308. PubMed ID: 32388223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interfacing microbore and capillary liquid chromatography to continuous-flow fast atom bombardment mass spectrometry for the analysis of glycopeptides.
    Coutant JE; Chen TM; Ackermann BL
    J Chromatogr; 1990 Aug; 529(2):265-75. PubMed ID: 2146280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacokinetics of individual teicoplanin components in patients.
    Hanada K; Ikari S; Koukaki Y; Utena A; Kimura T; Hamano K; Ariki H; Masuhara K; Ogata H
    Biol Pharm Bull; 2007 May; 30(5):952-4. PubMed ID: 17473441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of teicoplanin to human serum albumin.
    Assandri A; Bernareggi A
    Eur J Clin Pharmacol; 1987; 33(2):191-5. PubMed ID: 2961570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actinoplanes teichomyceticus ATCC 31121 as a cell factory for producing teicoplanin.
    Taurino C; Frattini L; Marcone GL; Gastaldo L; Marinelli F
    Microb Cell Fact; 2011 Oct; 10():82. PubMed ID: 22008254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of urinary metabolites of ecabapide in rat.
    Fujimaki Y; Hosokami T; Ono K
    Xenobiotica; 1995 May; 25(5):501-10. PubMed ID: 7571723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of teicoplanin in human plasma and urine by affinity and reversed-phase high-performance liquid chromatography.
    Riva E; Ferry N; Cometti A; Cuisinaud G; Gallo GG; Sassard J
    J Chromatogr; 1987 Oct; 421(1):99-110. PubMed ID: 2963015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung and serum teicoplanin concentration after aerosol and intravenous administration in a rat model.
    Mercier E; Darrouzain F; Montharu J; Guillon A; Diot P; Paintaud G; Vecellio L
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):306-12. PubMed ID: 24320618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved quantitative determination of total and unbound concentrations of six teicoplanin components in human plasma by high performance liquid chromatography.
    Hanada K; Kobayashi A; Okamori Y; Kimura T; Ogata H
    Biol Pharm Bull; 2005 Oct; 28(10):2023-5. PubMed ID: 16204971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal penetration of teicoplanin.
    Briggs MC; McDonald P; Bourke R; Smith G; McGalliard JN; Wong D
    Eye (Lond); 1998; 12 ( Pt 2)():252-5. PubMed ID: 9683949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian approach to drug disposition evaluation: application to teicoplanin.
    Ferrante L; Bompadre S; Cingolani ML; Leone L
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):410-4. PubMed ID: 7582399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.